Co-Diagnostics, Inc.
CODX • NASDAQ
Co-Diagnostics, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Dwight H. Egan, with a market cap of $3.7M.
CEODwight H. Egan
Next Earnings
Upcoming earnings announcement for Co-Diagnostics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.60
Revenue Estimate
$200.0K
Earnings History
Past 11 earnings reports for Co-Diagnostics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.16Est: -$0.19 | +15.8% | $145.4KEst: $300.0K | -51.5% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.23Est: -$0.25 | +8.0% | $162.9KEst: $300.0K | -45.7% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.24Est: -$0.33 | +27.3% | $50.3KEst: $375.0K | -86.6% | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.36Est: -$0.34 | -5.9% | $149.3KEst: $375.0K | -60.2% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.32Est: -$0.33 | +3.0% | $641.1KEst: $370.0K | +73.3% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.25Est: -$0.34 | +26.5% | $2.7MEst: $370.0K | +617.8% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.31Est: -$0.21 | -47.6% | $467.9KEst: $3.1M | -84.7% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.50Est: -$0.20 | -150.0% | $3.6MEst: $3.6M | -1.8% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.20Est: -$0.29 | +31.0% | $2.5MEst: $200.0K | +1128.5% | — |
| Aug 10, 2023 | Q2 2023 | -$0.31Est: -$0.24 | -29.2% | $197.8KEst: $500.0K | -60.4% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.20Est: -$0.22 | +9.1% | $602.0KEst: $1.1M | -45.3% | 10-Q |